MelUstadweb.png

Mel Ustad
Director of Commercialization at the Governor's Office of Economic Development.

mdt.png 

JEFFREY STEINLE, Esq., Fredrikson & Bryon, P.A.


Keynote >> MIKE THOMPSON,
Dr. Michael Thompson is Vice President of PartnerDevelopment with Benson Hill Biosystems. He is personally passionate about eliminating poverty and hunger and professionally responsible for improving crop performance through adoption of Benson Hill’s proprietary computational and systems biology platform, CropOS™. Prior to joining Benson Hill, he served as Director of GlobalSales and Market Development for Illumina’s Agriculture business. He previously the DNA Technologies division of BioDiagnostics, Inc. and held leadership positions in research and technology development at Monsanto.


 

England.png

Kristi Egland, PhD
Kristi Egland, PhD attended college at Washington University in St. Louis, MO. She received her Ph.D. in Molecular Biology from the University of Iowa. After studying immunotherapies as a post-doctoral fellow at the National Cancer Institute in Bethesda, MD, she joined Sanford Research and established her breast cancer research program.

 Hennings.png DR. JANE CHRISTOPHER-HENNINGS
Center For Biologics Research & Commercialization Dr. Jane Christopher-Hennings is the PI for the Governor’s Office of Economic  Development Center for Biologics Research & Commercialization, Head of the SDSU, Veterinary and Biomedical Sciences Department and Director of the SD Animal Disease Research and Diagnostic Laboratory.  She has BS and MS Degrees from the University of Wisconsin-Madison; DVM from the University of Minnesota and is currently a Full Professor at SDSU. She has published >70 manuscripts and 6 book chapters while successfully obtaining grant funding (>$7 million) and intellectual property license agreements and patent applications.  
RobbWinters.png  ROBB WINTERS, Ph.D.
South Dakota Biofilm Science and Engineering Center - NSF EPSCoR
Robb Winter is the department head and professor of chemical and biological engineering at South Dakota School of Mines & Technology. He current leads the research effort of the National Science Foundation Track 1 proposal to create the SD Biofilm Science and Engineering Center and is program director for more than $8 million in contracts with the U.S. Air Force to conserve energy at forward operating bases. In that role he has guided the development of the Composites and Polymer Engineering Laboratory and collaborated on the creation of the Center for Bioprocessing Research and Development.
 
 BillGibbons.png WILLIAM GIBBONS, Ph.D.              
SD Oilseeds Research Initiative
Gibbons is an accomplished researcher focused on applied microbiology and biotechnology, specifically in value addition to agricultural products through bioprocessing. Most of the students he has trained have gone on to work in the biotechnology industry. He has practiced and promoted interdisciplinary research and has a strong network of collaborators.
CB.png  CHRISTOPH L. BAUSCH, Ph.D.
SAB Biotherapeutics
Dr. Christoph L. Bausch is the chief science officer of SAB Biotherapeutics, a clinical-stage biopharmaceutical development company commercializing the first-of-its-kind immunotherapy platform to produce full human polyclonal (IgG) antibodies from bovine –The DiversitAb™ Platform. Dr. Bausch is responsible for antibody and antigen production, quality control laboratories, research collaborations, grant funding and clinical studies. Prior to SAB, Dr. Bausch worked in business development for global biorefining leader, Poet, LLC, where he structured strategic partnerships, prospected and vetted new technologies, and streamlined R&D. He also held research and commercialization roles for Fortune 500 life science company Sigma-Aldrich.
 

Ehli.png 

massy.png

scholl.png

ERIK EHLI, Ph.D., BSN
Avera Institute For Human Genetics
Dr. Erik Ehli is the Scientific Director at the Avera Institute for Human Genetics and an Assistant Professor within the University Of South Dakota Department Of Psychiatry. Dr. Ehli’s research interests lie in the molecular genetic mechanisms of complex diseases, with a strong focus on twin, cancer, and pharmacogenetics.

 

 

 

 

ADRIANNE MASSEY, Ph.D., BIO
Dr. Adrianne Massey began her professional career as a faculty member in the Biology Department of NC State University. She left academia to serve as Vice President of the NC Biotechnology Center, where she directed the Center's award-winning biotechnology education, work force training and public outreach programs.
Most recently, Dr. Massey served as Managing Director for Science and Regulatory Affairs at BIO in Washington, D.C.
She is the co-author of three textbooks on the science, applications and societal issues of medical, agricultural and industrial biotechnology.




DANIEL SCHOLL Ph.D., SDSU
Daniel Scholl is vice president for research and economic development at South Dakota State University. Scholl joined SDSU in 2011 as as associate dean for research of the College of Agriculture and Biological Sciences and director of the South Dakota Agricultural Experiment Station. Previously at the University of Montreal, he led a team that founded an international research consortium with the Canadian Natural Sciences and Engineering Research Council and several industry partners.